Bingham, Clifton O. III
Black, Shawn
Shiff, Natalie J.
Xu, Stephen
Langholff, Wayne
Curtis, Jeffrey R.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
https://doi.org/10.1007/s40744-021-00354-4
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
https://doi.org/10.1186/s41927-023-00329-8
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
https://doi.org/10.1007/s40744-023-00533-5
Funding for this research was provided by:
Janssen Research and Development
Article History
Received: 11 November 2022
Accepted: 11 January 2023
First Online: 23 February 2023